Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchoprotection of Salbutamol in Asthma and COPD
NCT00440245Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Feb 2007
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol in asthma, chronic obstructive pulmonary disease (COPD), sponsored by University of Saskatchewan. Started Feb 2007; status: completed.
02
Drugs
salbutamol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00440245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440245.